Table 2.
Description | Number |
---|---|
Squamous cell carcinoma | 21 |
Adenocarcinoma | 20 |
Neuroendocrine NSCLC | 3 |
Poorly differentiated carcinoma | 5 |
Total on study: | 49 |
Excluded: | |
- Metastatic | 4 |
- Carcinoid | 1 |
- No cells in sample | 7 |
- Contamination of sample/culture | 2 |
- Failure of assay | 1 |
Total | 64 |